Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 18611 - 18620 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02436981 | MINT-OLANZAPINE ODT 15MG | Standard Benefit for Eligible Clients |
02437007 | MINT-OLANZAPINE ODT 20MG | Standard Benefit for Eligible Clients |
02437031 | DOCETAXEL INJ IV 20MG/ML | Standard Benefit for Eligible Clients |
02437058 | GARDASIL 9 SUSP INJ IM | Standard Benefit for Eligible Clients |
02437082 | DULOXETINE DR CAP 30MG | Standard Benefit for Eligible Clients |
02437090 | DULOXETINE DR CAP 60MG | Standard Benefit for Eligible Clients |
02437104 | CEFAZOLIN FOR INJECTION PWS IV 500MG/VIAL | Standard Benefit for Eligible Clients |
02437112 | CEFAZOLIN FOR INJECTION PWS IV 1GM/VIAL | Standard Benefit for Eligible Clients |
02437120 | CEFAZOLIN FOR INJECTION PWS IV 10GM/VIAL | Standard Benefit for Eligible Clients |
02437139 | MYLAN-PALIPERIDONE EXTENDED RELEASE TAB 6MG | Standard Benefit for Eligible Clients |
Displaying 18611 - 18620 of 24215